Try Pro free
Log In

Syros Pharmaceuticals



Total Funding Amount $158M
CB Rank (Company) 12,780
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that is focused on treating diseases by mapping gene regulatory circuits.
  • IPO Status Public
  • Stock Symbol  NASDAQ:SYRS
  • Company Type For Profit

Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical R&D.

Central to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros' senior leadership. While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

Read More

Unlock Charts on Crunchbase

Charts can be found on various organization profiles and on Hubs pages, based on data availability.

Start your free trial

Lists Featuring This Company

Northeastern US Biotechnology Companies
2,884 Number of Organizations • $81.3B Total Funding Amount • 5,629 Number of Investors
Fidelity Management and Research Company Portfolio Companies
76 Number of Organizations • $33.9B Total Funding Amount • 1,118 Number of Investors
Life Science Public Companies
146 Number of Organizations • $20.8B Total Funding Amount • 386 Number of Investors
East Coast Biotechnology Public Companies
400 Number of Organizations • $40.2B Total Funding Amount • 1,606 Number of Investors

IPO & Stock Price

Syros Pharmaceuticals is registered under the ticker NASDAQ:SYRS . Their stock opened with $12.50 in its Jun 30, 2016 IPO.
  • Stock Symbol  NASDAQ:SYRS
  • Money Raised at IPO $50M
  • IPO Share Price $12.50
  • IPO Date Jun 30, 2016
Stock chart by

Funding Rounds

Number of Funding Rounds 4
Total Funding Amount $158M
Syros Pharmaceuticals has raised a total of $158M in funding over 4 rounds. Their latest funding was raised on Apr 26, 2017 from a Post-IPO Equity round.Which funding types raised the most money?ShowHow much funding has this organization raised over time?Show
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Apr 26, 2017
Post-IPO Equity - Syros Pharmaceuticals
Jan 12, 2016
Series C - Syros Pharmaceuticals
Sign up for free to unlock and follow the latest funding activities
$40M Deerfield
Oct 27, 2014
Series B - Syros Pharmaceuticals
Apr 11, 2013
Series A - Syros Pharmaceuticals
2$30M ARCH Venture Partners, Flagship Pioneering


Company Tech Stack by G2 Stack

Syros Pharmaceuticals uses 15 technology products and services including HTML5Google Analytics, and jQuery.

Website Tech Stack by BuiltWith

Syros Pharmaceuticals is actively using 37 technologies for its website. These include Viewport MetaIPhone / Mobile Compatible, and Google Analytics.

Web Traffic by SimilarWeb

Syros Pharmaceuticals is ranked 3,305,738 among websites globally based on its 2,361 monthly web visitors.

Interest Signals by Bombora

Syros Pharmaceuticals employees are showing high interest in San Francisco, CaliforniaSymposium, and Economic Diversification.

IT Spend by Aberdeen

Current Team

Number of Current Team Members 5
Syros Pharmaceuticals has 5 current team members, including Co-Founder Nathanael Gray.

Board Members and Advisors

Number of Board Members / Advisors 3
Syros Pharmaceuticals has 3 board members and advisors, including Mark Murcko.

Recent News & Activity

Number of Articles 54

Related Hubs

Sign up for a free Crunchbase account to follow and track profiles you care about.

Terms of Service | Privacy Policy | Sitemap | © 2020 Crunchbase Inc. All Rights Reserved. (c14e508 211)